The average
share price target for Alphamab Oncology is 9.60. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$9.60 ,and the lowest forecast is HK$9.60. The average share price target represents 2.24% Increase from the current price of HK$9.39.